ReviewThe pharmacogenomics journal2005

Will investments in biobanks, prospective cohorts, and markers of common patterns of variation benefit other populations for drug response and disease susceptibility gene discovery?

M W Foster et al.PubMed ↗Publisher ↗

No numbers read from the abstract.